The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...
St. Joseph's Hospital was identified as one of the nation's 50 Top Cardiovascular Hospitals®, according to an independent ...
The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.
Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.
Veterans with apnea-hypopnea index scores implying no sleep apnea or severe sleep apnea had higher all-cause mortality rates ...
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).
In a significant development for organ transplantation, two U.S. biotechnology companies, United Therapeutics and ...
Moderate-to-severe tricuspid regurgitation (TR) has a high prevalence in the general population, 1 and it progressively increases in older individuals, in whom it is close to 4%.